06/12/2026
Okay, can we talk for a second? NAD+ IVs had a great run. We get it — 2023 called it the wellness "it" drip. 💁♀️
But the science has moved on, and so have we.
Enter Niagen® (nicotinamide riboside, aka NR) — the next generation of cellular support, and it's not just "the new NAD+." It's actually backed by something NAD+ IV never had: real clinical research.
Here's what the data shows:
🔬 A randomized, placebo-controlled pilot study found Niagen® IV raised NAD+ levels by more than 20% within 3 hours — with 75% less infusion time than traditional NAD+ IV, and fewer/less severe side effects during the drip.
🔬 A 2026 peer-reviewed study in Frontiers in Aging compared NAD+ IV head-to-head with NR IV in a real-world clinic setting (4 days of infusions, 30-day follow-up) and confirmed it again: NR was the better-tolerated option.
Translation: less time in the chair, fewer "why does my chest feel weird" moments, and a therapy that's actually been studied this way — not just trendy.
This is exactly why having an actively engaged (and present) Medical Director matters. At Fit Living in Progress, we don't just add whatever's popular to the menu. Our Chief Clinical Officer👨⚕️, Joe Christensen, reviews the research, vets the sourcing, and collaborates with CEO👨💼Brent Lankford to decide what we're willing to put our name behind. That's the difference between an integrative functional medicine practice with IVs and an IV lounge with a fridge full of vials.
We're proud to offer Niagen® IV and Niagen® Shots, sourced through Niagen Plus — pharmaceutical-grade, administered by licensed professionals, under real medical oversight.
Ready to feel the difference? Book your Niagen® session today. 💙
📲 https://www.tebra.com/care/provider/joseph-christensen-aprn-fnp-bc-1649974965
*These statements have not been evaluated by the FDA. This product is not intended to diagnose, treat, cure, or prevent any disease.
